Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China flag China · Delayed Price · Currency is CNY
16.36
+0.51 (3.22%)
Jun 12, 2026, 3:00 PM CST
Market Cap6.90B +19.8%
Revenue (ttm)1.03B -5.7%
Net Income22.53M -91.1%
EPS0.05 -91.0%
Shares Out 421.46M
PE Ratio305.98
Forward PEn/a
Dividend0.20 (1.26%)
Ex-Dividend DateJun 13, 2025
Volume6,476,292
Open16.08
Previous Close15.85
Day's Range15.99 - 16.42
52-Week Range15.11 - 28.28
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:688553

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor injection in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. It also offers moroxydine sodium chloride, ... [Read more]

Sector Healthcare
Founded 2010
Employees 1,366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688553
Full Company Profile

Financial Performance

Financial Statements